Stock comparison
Eli Lilly
Medpace Holdings
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$946.37B
Sector
Healthcare
MEDP
Medpace Holdings
Market cap
$11.86B
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | MEDP | Winner |
|---|---|---|---|
| Warren Buffett | 65B | 53C | LLY |
| Benjamin Graham | 76B | 59C | LLY |
| Philip Fisher | 75B | 62C | LLY |
| Peter Lynch | 64C | 57C | LLY |
| Joel Greenblatt | 68B | 71B | MEDP |
| Charlie Munger | 75B | 59C | LLY |
| Terry Smith | 66B | 67B | MEDP |
Side-by-side metrics
| Metric | LLY | MEDP |
|---|---|---|
| Market cap | $946.37B | $11.86B |
| P/E (TTM) | 35.6x | 25.7x |
| EV/EBIT | 33.2x | 21.2x |
| ROIC (TTM) | 32.06% | 56.06% |
| Gross margin | 83.51% | 29.07% |
| Net margin | 34.98% | 17.19% |
| Revenue CAGR 5y | 23.17% | 21.99% |
| EPS CAGR 5y | 40.81% | 32.59% |
| Debt / Equity | 1.4x | 0.2x |
| Dividend yield | 0.64% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- Dividend yield0.64%vs 0.0%+100%
- Market cap$946.37Bvs $11.86B+99%
- Gross margin83.51%vs 29.07%+65%
- Net margin34.98%vs 17.19%+51%
MEDP leads on
- Debt / Equity0.2xvs 1.4x+82%
- ROIC (TTM)56.06%vs 32.06%+43%
- EV/EBIT21.2xvs 33.2x+36%
- P/E (TTM)25.7xvs 35.6x+28%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.